BRPI0509117A - método de liofilização para melhorar a cristalização de excipientes - Google Patents

método de liofilização para melhorar a cristalização de excipientes

Info

Publication number
BRPI0509117A
BRPI0509117A BRPI0509117-9A BRPI0509117A BRPI0509117A BR PI0509117 A BRPI0509117 A BR PI0509117A BR PI0509117 A BRPI0509117 A BR PI0509117A BR PI0509117 A BRPI0509117 A BR PI0509117A
Authority
BR
Brazil
Prior art keywords
crystallization
high temperature
excipient
cooling step
excipients
Prior art date
Application number
BRPI0509117-9A
Other languages
English (en)
Inventor
Jennifer Juneau
Susan Knowles
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0509117A publication Critical patent/BRPI0509117A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MéTODO DE LIOFILIZAçãO PARA MELHORAR A CRISTALIZAçãO DE EXCIPIENTES.A presente invenção fornece métodos melhorados para liofilizar (congelamento a vácuo) componentes ativos como proteína, ácidos nucléicos e vírus. Os presentes métodos melhoram o grau de cristalização do excipiente durante o processo de liofilização em comparação aos métodos an teriores. A melhora na cristalização do excipiente é baseada, em parte, em uma etapa de arrefecimento a alta temperatura que é conduzida antes da ou ao menos tempo que a secagem secundária. De modo importante, a etapa de arrefecimento a alta temperatura não desestabiliza os componentes ativos. Além disso, a etapa de arrefecimento a alta temperatura não necessita das etapas de arrefecimento sub-zero antes da sua ratificação de modo a fornecer a completa cristalização do excipiente.
BRPI0509117-9A 2004-03-04 2005-03-04 método de liofilização para melhorar a cristalização de excipientes BRPI0509117A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55002004P 2004-03-04 2004-03-04
US58014004P 2004-06-15 2004-06-15
PCT/US2005/006872 WO2005089712A1 (en) 2004-03-04 2005-03-04 Lyophilization method to improve excipient crystallization

Publications (1)

Publication Number Publication Date
BRPI0509117A true BRPI0509117A (pt) 2007-08-28

Family

ID=34993419

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509117-9A BRPI0509117A (pt) 2004-03-04 2005-03-04 método de liofilização para melhorar a cristalização de excipientes

Country Status (7)

Country Link
US (1) US20050226893A1 (pt)
EP (1) EP1720519A1 (pt)
JP (1) JP2007526329A (pt)
AU (1) AU2005225000A1 (pt)
BR (1) BRPI0509117A (pt)
CA (1) CA2554018A1 (pt)
WO (1) WO2005089712A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004007526A1 (de) * 2004-02-17 2005-09-01 Oetjen, Georg-Wilhelm, Dr. Verfahren und Einrichtung zur Gefriertrocknung von Produkten
AU2006272804B2 (en) * 2005-07-22 2011-02-24 Amgen Inc. Concentrated protein lyophilates, methods, and uses
DK1942868T5 (da) * 2005-11-01 2024-01-08 Wyeth Llc Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding
EP1951305A1 (en) * 2005-11-22 2008-08-06 Wyeth a Corporation of the State of Delaware Immunoglobulin fusion protein formulations
TW200730530A (en) * 2005-12-16 2007-08-16 Wyeth Corp Lyophilized compositions of a triazolopyrimidine compound
JP5415771B2 (ja) * 2006-02-03 2014-02-12 アクテリオン ワン エスエー 新規なエポプロステノール製剤およびその製造方法
EP1870650A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targeting defined residual moisture by limited desorption energy levels
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
RU2541784C2 (ru) * 2006-11-07 2015-02-20 Санофи Пастер Байолоджикс Ко. Лиофилизированная композиция для индукции иммунного ответа на флавивирус, композиция и способ для ее получения
JP5484041B2 (ja) * 2007-02-23 2014-05-07 学校法人関西学院 蛋白質結晶化剤および蛋白質結晶化剤を用いた蛋白質結晶化方法
RU2555332C2 (ru) 2009-11-03 2015-07-10 Грифольс Терапьютикс Инк. Композиция, способ и набор для альфа-1 ингибитора протеазы
RU2540480C2 (ru) * 2009-11-24 2015-02-10 Грифольс Терапьютикс Инк. Способы, композиции и наборы для лиофилизации
US9044498B2 (en) 2010-12-02 2015-06-02 Oncolytics Biotech Inc. Lyophilized viral formulations
SG190418A1 (en) 2010-12-02 2013-07-31 Oncolytics Biotech Inc Liquid viral formulations
US8609355B2 (en) 2011-07-26 2013-12-17 Indicator Systems International, Inc. Assays for the detection of microbes
TWI788044B (zh) 2013-03-15 2022-12-21 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物
MA39779A (fr) 2014-03-24 2017-02-01 Biogen Ma Inc Formulations de facteur ix lyophilisées
US11273127B2 (en) 2014-05-06 2022-03-15 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for thermally stable multi-targeted antigens
EP3241546B1 (en) 2014-12-30 2021-02-17 Samyang Biopharmaceuticals Corporation Polymer nanoparticle freeze-dried product, and preparation method therefor
TW202220639A (zh) * 2020-08-06 2022-06-01 英商４Ｄ製藥有限公司 凍乾方法
WO2023233277A1 (en) * 2022-05-31 2023-12-07 Zydus Lifesciences Limited Lyophilized pharmaceutical compositions of copper histidinate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
US5424471A (en) * 1992-07-31 1995-06-13 U.S. Bioscience, Inc. Crystalline amifostine compositions and methods of the preparation and use of same
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
CA2634664C (en) * 1999-02-22 2011-08-09 University Of Connecticut Novel albumin-free factor viii formulations

Also Published As

Publication number Publication date
JP2007526329A (ja) 2007-09-13
WO2005089712A1 (en) 2005-09-29
AU2005225000A1 (en) 2005-09-29
CA2554018A1 (en) 2005-09-29
US20050226893A1 (en) 2005-10-13
EP1720519A1 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
BRPI0509117A (pt) método de liofilização para melhorar a cristalização de excipientes
Adams The principles of freeze-drying
EA200500752A1 (ru) Способ и система для предварительной обработки для сжижения природного газа
ES540919A0 (es) Procedimiento para la inactivacion de germenes patogenos filtrables,capaces de reproducirse,en productos sanguineos
CN113652468A (zh) 一种适用于核酸检测试剂盒冻干的冻干保护剂及其冻干方法
BR112013027756A2 (pt) Método para remoção de hemoglobina não modificada de soluções de hemoglobina reticulada incluindo hemoglobina polimérica com equipamento para tratamento térmico a alta temperatura em curto período de tempo, composição farmaceutica derivada e método de oxigenação de tecido
BRPI9805021A (pt) processo para estabilizar proteínas em um processo de congelamento e liofilização ou durante armazenagem em baixas temperaturas, forma de armazenagem e composição farmacêutica.
Garner et al. Electrophoretic fractionation of bovine acrosomal proteins and proteinase
DK1648496T3 (da) Fremgangsmåde til stabilisering af et kryopræcipitat af plasmatiske proteiner, som er beregnet til at udsættes for en varmebehandling til virusinaktivering
Patel et al. A 31-kDa seminal plasma heparin–binding protein reduces cold shock stress during cryopreservation of cross-bred cattle bull semen
BR0100385A (pt) Procedimento para a produção de enxofrepolimérico
Lestari et al. Comparison of sperm parameters and DNA fragmentation index between infertile men with infection and vaccines of COVID-19
BR0100984A (pt) Processo para proteção de pelo menos umcompressor utilizado em uma bomba deaquecimento ou sistema de resfriamento
Mercati et al. Effect of chelating and antioxidant agents on morphology and DNA methylation in freeze‐drying rabbit (Oryctolagus cuniculus) spermatozoa
Namal Rathnayaka et al. Cardiac arrest and atrial fibrillation in a patient after hump-nosed pit viper (Hypnale hypnale) bite
Muer et al. Cryogenic changes in seminal protein of cattle and buffalo
WO2006128025A3 (en) Regulatory proteins in lung repair and treatment of lung disease
BRPI0407458A (pt) Solução de albumina e processo para sua preparação
Hubbard et al. Impact of residual moisture and formulation on Factor VIII and Factor V recovery in lyophilized plasma reference materials
Briner et al. Effect of lipoprotein lability on immunological properties of human low density lipoproteins.
Esmaeili Irani et al. The Antioxidant Effect of Apigenin on Human Sperm Quality after Freezing-Thawing
Reis et al. Effect of cholestanol loaded cyclodextrin in ram sperm on after criopreservation.
Wysocki et al. Is the phosphorylation status of tyrosine proteins a marker for the cryo-capacitation of boar spermatozoa
BRPI0415145B8 (pt) método para remover pelo menos uma parte de água de ácido adípico sólido e úmido
Abdulsattar et al. COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients.

Legal Events

Date Code Title Description
B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, REQUERIDA ATRAVES DA PETICAO NO 20090051073/RJ DE 26.05.2009.